A Mash Poa bus was set ablaze after a fatal accident in Salgaa. Eyewitnesses recounted the tragic incident, prompting outrage ...
Investing.com -- Altimmune Inc (NASDAQ:ALT) stock plunged 22.8% Friday after the company released 48-week data from its Phase 2b trial of pemvidutide for metabolic dysfunction-associated ...
There are certain rules about a war. Rule number one is young men die. And rule number two is, doctors can't change rule number one.” ...
Penn State will move on from the Jim Knowles experiment after only one season, according to several reports. Knowles is expected to become the new defensive coordinator at Tennessee, according to CBS ...
Altimmune, Inc. remains a high-risk, high-reward play as it approaches a pivotal 48-week MASH data readout for pemvidutide. ALT's pemvidutide shows strong MASH resolution and weight loss, but has not ...
People who have metabolic dysfunction-associated steatotic liver disease (MASLD) experience liver enlargement called hepatomegaly. They also develop fat deposits on their liver, which causes damage ...